PTGS2 and cancer: Remarkably, CTX-treated COX-2KO cells attracted far fewer neutrophils or monocytes than their parental COX-2-expressing counterpart, similar to untreated 4T1 cells (Fig. 5e), exposing a major contribution of cancer cell-intrinsic COX-2 activity.